ASCO Research Community Forum: Impact on clinical research.

Authors

David Waterhouse

David Michael Waterhouse

Oncology Hematology Care, Inc., Cincinnati, OH

David Michael Waterhouse, Nicholas J. Robert, Edward S. Kim, Dax Kurbegov, Howard A. Burris III, Michael A. Thompson, Grzegorz S. Nowakowski, Patricia A. Hurley, Courtney Davis, Rogerio Lilenbaum

Organizations

Oncology Hematology Care, Inc., Cincinnati, OH, 10101 Woodloch Forest, The Woodlands, TX, Levine Cancer Institute, Charlotte, NC, Sarah Cannon Cancer Institute, Nashville, TN, Sarah Cannon Research Institute, Nashville, TN, Advocate Aurora Health, Milwaukee, WI, Mayo Clinic, Rochester, MN, American Society of Clinical Oncology, Alexandria, VA, ASCO, Alexandria, VA, Yale University School of Medicine, New Haven, CT

Research Funding

No funding received
None.

Background: In 2011, ASCO launched a forum for the oncology research community to facilitate and promote the implementation of quality clinical research. The ASCO Research Community Forum (RCF) was created to provide a solution-oriented venue for research sites to address common challenges with conducting clinical trials. It offers in-person and virtual forums and resources to learn and share best practices with peers on a variety of topics, including site quality assessment and improvement, research site operations, and clinical trial access and accrual. Methods: An assessment was performed to measure the ASCO RCF output and to gather information on its potential impact on the cancer community. Results: The ASCO RCF has provided an in-person venue for physicians and research administrators with a steady increase in attendance, from 52 attendees in 2012 to 159 in 2018. Multi-stakeholder meetings and manuscripts have promoted best practices and solutions to address challenges with implementing quality clinical trials. Tools and resources to facilitate best practices and quality improvement at trial sites have been accessed by a range of types of research sites from across the U.S. and internationally. Its web-based library of resources was accessed over 27,000 times in 2018, alone. An online forum was launched in 2019 to provide a new opportunity to connect and impact the research community. Conclusions: The ASCO RCF is a productive and esteemed resource for the cancer research community. In-person and virtual forums, along with practical tools, promote access and accrual to clinical trials by facilitating networking, developing solutions, and providing education and resources. The ASCO RCF impact has extended from community-based oncology practices to larger research networks and academic centers across the U.S. and internationally. Its efforts to promote and facilitate access to quality clinical trials align with the vision and mission of ASCO to conquer cancer through research, education, and promotion of the highest quality patient care.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care

Track

Patient Experience,Technology and Innovation in Quality of Care,Safety

Sub Track

Tools to Reduce or Eliminate Regulatory and Administrative Burden

Citation

J Clin Oncol 37, 2019 (suppl 27; abstr 299)

DOI

10.1200/JCO.2019.37.27_suppl.299

Abstract #

299

Poster Bd #

K6

Abstract Disclosures

Similar Abstracts

Abstract

2014 ASCO Quality Care Symposium

ASCO research program quality assessment tool: Basics for a quality community-based research site.

First Author: Patricia A. Hurley

First Author: Susan S. Night